• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    Momenta Pharmaceuticals Inc. (MNTA)

    -NasdaqGS
    21.27 Down 1.16(5.17%) 4:00PM EDT
    |After Hours : 21.27 Up 0.00 (0.02%) 5:10PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 52,250   35,465   63,921  
    Cost of Revenue -   -   -  
    Gross Profit 52,250   35,465   63,921  
    Operating Expenses
    Research Development106,482  103,999  80,345  
    Selling General and Administrative45,164  41,057  43,682  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (99,396) (109,591) (60,106)
    Income from Continuing Operations
    Total Other Income/Expenses Net796  1,183  1,458  
    Earnings Before Interest And Taxes(98,600)(108,408)(58,648)
    Interest Expense -   -   -  
    Income Before Tax(98,600)(108,408)(58,648)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(98,600)(108,408)(58,648)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (98,600) (108,408) (58,648)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (98,600) (108,408) (58,648)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.